focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 12,088.00
Ask: 12,092.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,090.00
High: 12,118.00
Low: 12,038.00
Prev. Close: 12,110.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ireland sees strong early evidence that vaccines are working

Thu, 25th Feb 2021 19:03

By Padraic Halpin

DUBLIN, Feb 25 (Reuters) - Ireland is beginning to see
strong early evidence that its COVID-19 vaccine rollout is
protecting healthcare workers and care home residents from
catching the disease, health officials said on Thursday.

Ireland has administered almost 360,000 vaccines among its
population of 4.9 million, so far to healthcare workers, care
home residents and most recently people aged over 85. Just over
133,000 of those have received the second of their two doses.

The officials pointed to a sharp fall in the number of
healthcare workers contracting COVID-19 to below 300 last week
from almost 1,400 in the final week in January.

Ireland is mainly relying on the Pfizer-BioNTech
COVID-19 vaccine and has administered much smaller
amounts of the Moderna and AstraZeneca shots.

There were also fewer than 200 cases in care homes last week
versus 1,250 three weeks ago while the relative number of deaths
in hospitals and homes are falling more rapidly than elsewhere
after Ireland suffered its deadliest wave to date last month.

"Very hearteningly, we think we are beginning to see strong
early evidence of a protective impact of vaccination on those
cohorts that are in the course of being vaccinated at present,"
Ireland's COVID-19 modelling chief Philip Nolan told a news
conference.

The government has said if vaccines arrive on schedule, 55%
to 60% of people will be fully vaccinated by the end of June.

Nolan added that even though the rate of decline in cases
has slowed in the last two weeks, Ireland continued to make
"significant progress" against all indicators of disease during
a lockdown that was extended into April this week.

The reproduction number - the number of people infected by
someone with COVID-19 - remained steady at 0.6 and 0.9, despite
the near dominance of the more infectious B1.1.7 variant first
detected in Britain.

The number of cases per 100,000 people in the past 14 days
has fallen to 226 from a high of over 1,500 less than six weeks
ago.

"Continue doing what you're doing. We've gone from a
situation where six, seven weeks ago we were the worst in the
world and through the actions of people, we are now in the top
10 in Europe," Deputy Chief Medical Officer Ronan Glynn said.
(Reporting by Padraic Halpin; editing by David Evans)

More News
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.